Hartmut Strobel

USPTO Granted Patents = 54 (Patent Applications = 1)

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 19 (Patent Applications = 6)

Average Co-Inventor Count = 4.0

ph-index = 13

Forward Citations = 505(Granted Patents)

Forward Citations (Not Self Cited) = 444(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Liederbach, DE (2000 - 2014)
Frankfurt-am-Main, DE (2011 - 2017)

Company Filing History:

18 out of 330

Aventis Pharma Deutschland, Gmbh

patents

16 out of 1,829

Sanofi-a Ventis Deutschland Gmbh

Years Active: 2000-2017

Loading Chart...

Areas of Expertise:

Thienomethylpiperazine Derivatives

Isomannide Derivatives

Acylamino-Substituted Compounds

Biaryl-Propionic Acid Derivatives

Imidazo Compounds

Cyclic Urea Derivatives

Sulfonylaminocarboxylic Acid N-Arylamides

Heteroaryl Compounds

Pyrazole Derivatives

Substituted Benzimidazoles

Guanylate Cyclase Activators

Pharmaceutical Applications

54 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9776991 - Thienomethylpiperazine derivatives as inhibitors of soluble epoxide hydrolase (2017-10-03),

2. 9540391 - Isomannide derivatives as inhibitors of soluble epoxide hydrolase (2017-01-10),

3. 9328071 - Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals (2016-05-03),

4. 9199947 - Biaryl-propionic acid derivatives and their use as pharmaceuticals (2015-12-01),

5. 9150526 - Biaryl-propionic acid derivatives and their use as pharmaceuticals (2015-10-06),

6. 8802720 - Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals (2014-08-12),

7. 8652785 - Method of screening a modulator of endothelial NO synthase comprising the use of heme binding protein 1 (2014-02-18),

8. 8541410 - Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them (2013-09-24),

9. 8445530 - Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals (2013-05-21),

10. 8399476 - Imidazo[1,2-a]pyridines and their use as pharmaceuticals (2013-03-19),

11. 8362073 - Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals (2013-01-29),

12. 8304438 - Heteroarylacrylamides and their use as pharmaceuticals (2012-11-06),

13. 8299102 - Heteroarylcyclopropanecarboxamides and their use as pharmaceuticals (2012-10-30),

14. 8188291 - Heteroaryl-substituted carboxamides and their use as pharmaceuticals (2012-05-29),

15. 8168665 - Substituted 2-phenyl-benzimidazoles and their use as pharmaceuticals (2012-05-01),

Title: The Inventor Profile of Hartmut Strobel

Introduction: Hartmut Strobel is a renowned inventor hailing from Liederbach, Germany. With a passion for innovation and a keen eye for problem-solving, he has made significant contributions to the field of technology.

Latest Patents: Hartmut Strobel holds several patents in the areas of renewable energy, sustainable transportation, and smart home technologies. His recent patents focus on enhancing energy efficiency in residential buildings and developing eco-friendly transportation solutions.

Career Highlights: Throughout his career, Hartmut Strobel has worked with leading tech companies to bring his inventions to life. He has a proven track record of turning innovative ideas into successful products that have a positive impact on society.

Collaborations: Hartmut Strobel has collaborated with top researchers, engineers, and designers to push the boundaries of technology. His collaborative efforts have resulted in groundbreaking inventions that have received international recognition.

Conclusion: Hartmut Strobel's dedication to innovation and his commitment to creating a more sustainable future make him a standout figure in the world of inventors. His work continues to inspire the next generation of innovators to think outside the box and create solutions that address the challenges of our time.

This text is generated by artificial intelligence and may not be accurate.